Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Newmont (NEMCL) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Newmont (NEMCL) over the last 13 years, with Q3 2025 value amounting to $2.9 billion.

  • Newmont's Operating Expenses fell 1521.43% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 billion, marking a year-over-year decrease of 3238.14%. This contributed to the annual value of $14.2 billion for FY2024, which is 475.87% up from last year.
  • Per Newmont's latest filing, its Operating Expenses stood at $2.9 billion for Q3 2025, which was down 1521.43% from $2.2 billion recorded in Q2 2025.
  • Newmont's 5-year Operating Expenses high stood at $6.8 billion for Q4 2023, and its period low was $2.0 billion during Q1 2021.
  • Moreover, its 5-year median value for Operating Expenses was $2.8 billion (2025), whereas its average is $3.1 billion.
  • Over the last 5 years, Newmont's Operating Expenses had its largest YoY gain of 6665.13% in 2024, and its largest YoY loss of 4543.3% in 2024.
  • Over the past 5 years, Newmont's Operating Expenses (Quarter) stood at $4.0 billion in 2021, then rose by 15.31% to $4.6 billion in 2022, then surged by 46.1% to $6.8 billion in 2023, then crashed by 45.43% to $3.7 billion in 2024, then fell by 20.15% to $2.9 billion in 2025.
  • Its last three reported values are $2.9 billion in Q3 2025, $2.2 billion for Q2 2025, and $2.8 billion during Q1 2025.